Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS seeks amendments to Reye's syndrome bill

Executive Summary

Natl. Assn. of Chain Drug Stores in comments to House Commerce/Health Subcmte. Chairman Waxman (D-Calif.) said bill to require retailers to provide within 30 days of enactment warning notices, advertising, and new labeling regarding the association between aspirin and Reye's syndrome would pose logistical compliance problems. Assn. urged "a more reasonable timetable" of 60 days for retail warning notices, 90 days to bring ads into compliance, and 270 days to relabel.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS008173

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel